allergy banner

Videos


Open Access Agreements with Wiley



Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley

Free access

Articles


Presentation of airway and general symptoms in COVID-19 caused by dominant SARS-CoV-2 variants: a follow-up on ARIA consensus

Hagemann, J., Onorato, G., Seifen, C., et al. Allergy. First published: 22 June 2022

Food allergy, mechanisms, diagnosis and treatment: Innovation through a multi-targeted approach

Sindher, S.B., Long, A., Chin, A.R., et al. Allergy. First published: 22 June 2022

Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity

Worm, M., Alexiou, A., Bauer, A., et al. Allergy. First published: 20 June 2022

Structural and functional analyses of antibodies specific for modified core N-glycans suggest a role in TH2 responses

Plum, M., Tjerrild, L., Raiber, T., et al. Allergy. First published: 20 June 2022

Intranasal antihistamine and corticosteroid to treat in allergic rhinitis: A systematic review and meta-analysis

Kim, M., Ryu, G., Kang, S.-Y., et al. Allergy. First published: 18 June 2022

Absence of NLRP3 somatic mutations and VEXAS-related UBA1 mutations in a large cohort of patients with Schnitzler syndrome

Louvrier, C., Awad, F., Amselem, S., Lipsker, D. and Giurgea, I. Allergy. First published: 14 June 2022

Omics technologies in allergy and asthma research: an EAACI position paper

Radzikowska, U., Baerenfaller, K., Cornejo-Garcia, J.A., et al. Allergy. First published: 17 June 2022

CRISPR screening reveals mechanisms of IgE+ B-cell constraint

Awan, S.F., Haque, T.T. and Kubala, S.A. Allergy. First published: 16 June 2022

Cell type eQTL deconvolution of bronchial epithelium through integration of single-cell and bulk RNA-seq

Qi, C., Berg, M., Chu, X., et al. Allergy. First published: 16 June 2022

High-dimensional immune profiles correlate with phenotypes of peanut allergy during food-allergic reactions

Klueber, J., Czolk, R., Morel-Codreanu, F., et al. Allergy. First published: 14 June 2022

Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection

Maurer, D.J., Barletta, E., Heider, A., et al. Allergy. First published: 12 June 2022

IL-13, an essential cDC2s partner to maintain skin homeostasis

Fernández-Santamaría, R., Cañas, J.A. and Aranda, C. Allergy. First published: 12 June 2022

Prenatal antibiotic exposure, asthma and the atopic march: A systematic review and meta-analysis

Cait, A., Wedel, A., Arntz, J.L., et al. Allergy. First published: 11 June 2022

Soluble ST2 enhances IL-33–induced neutrophilic and pro-type 2 inflammation in the lungs

Watanabe, M., Nakamoto, K., Inui, T., et al. Allergy. First published: 05 June 2022

Legends of allergy and immunology: Richard F. Lockey

Fernandez-Caldas, E. Allergy. First published: 04 June 2022

Secretory RAS cells: A novel AT2 progenitor in the human transitional bronchioles

McGrath, J.J.C. and Cass, S.P. Allergy. First published: 04 June 2022

Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection

Rose, R., Neumann, F., Müller, S., et al. Allergy. First published: 02 June 2022

The SCF/KIT axis in human mast cells: Capicua acts as potent KIT repressor and ERK predominates PI3K

Franke, K, Kirchner, M, Mertins, P, et al. Allergy. First published: 02 June 2022

Cow's milk and egg protein threshold dose distributions in children tolerant to beef, baked milk, and baked egg

Valluzzi, RL, Riccardi, C, Arasi, S, et al. Allergy. First published: 02 June 2022

Signatures of positive selection are enriched in genome-wide associated allergy alleles

Li, J., Zhang, X., Gao, Y., et al. Allergy. First published: 02 June 2022

Correspondence to " Emollients in infancy to prevent atopic dermatitis: A systematic review and meta-analysis"

Kelleher, M.M., Cro, S., Phillips, R., et al. Allergy. First published: 29 May 2022

Reply to correspondence: Emollients in infancy to prevent atopic dermatitis: A systematic review and meta-analysis

Zhong, Y., Samuel, M., van Bever, H. and Tham, E.H. Allergy. First published: 29 May 2022

Nanobody-based human antibody formats act as IgE surrogate in hymenoptera venom allergy

Aagaard, J.B., Sivelle, C., Fischer, M., et al. Allergy. First published: 29 May 2022

Monkeypox outbreak in Europe, UK, North America, and Australia: A changing trend of a zoonotic disease

Cabanillas, B., Valdelvira, R. and Akdis, C.A. et al. Allergy. First published: 29 May 2022

Proteomics endotyping of infants with severe bronchiolitis and risk of childhood asthma

Ooka, T, Raita, Y, Fujiogi, M, et al. et al. Allergy. First published: 27 May 2022

Desert dust and respiratory diseases: Further insight on the epithelial barrier hypothesis

D’Amato, G. and Akdis, C.A. et al. Allergy. First published: 27 May 20222

Remission of peanut allergy is associated with rewiring of allergen-driven T helper 2-related gene networks

Ashley, SE, Jones, AC, Anderson, D, et al. Allergy. First published: 25 May 2022

NLRP6 negatively regulates type 2 immune responses in mice

Chenuet, P, Marquant, Q, Fauconnier, L, et al. Allergy. First published: 25 May 2022

Functional CTLA-4 variants associate to both allergic asthma and rhinitis potentially by modulating naïve regulatory T cells

Andiappan, A.K., Puan, K.J., Sio, Y.Y., et al. Allergy. First published: 24 May 2022

The role of hypoxia in the pathophysiology of chronic rhinosinusitis

Zhong, B, Seah, JJ, Liu, F, et al. Allergy. First published: 23 May 2022

Metabolomics to identify omalizumab responders among children with severe asthma: a prospective study

Carraro, S., di Palmo, E., Licari, A., et al. Allergy. First published: 23 May 2022

Citations: 1421

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Citations: 409

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

Citations: 258

COVID-19 in a designated infectious diseases hospital outside Hubei Province, China

Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752

Citations: 206

Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors

Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844

Citations: 192

Eleven faces of coronavirus disease 2019

Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709

Citations: 159

Risk factors for severe and critically ill COVID-19 patients: A review

Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455

Citations: 91

Type 2 immunity in the skin and lungs

Akdis, CA, Arkwright, PD, Brüggen, MC, et al. Allergy. 2020; 75: 1582– 1605

Citations: 87

Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2

Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812

Citations: 69

Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444

Citations: 69

Towards a more precise diagnosis of hypersensitivity to beta-lactams — an EAACI position paper

Romano, A, Atanaskovic-Markovic, M, Barbaud, A, et al. Allergy. 2020; 75: 1300– 1315

Citations: 69

Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?

Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Unexplained recurrent fever: when is autoinflammation the explanation?

Kallinich, T., Gattorno, M., Grattan, C.,E., de Koning, H.,D., Traidl-Hoffmann, C., Feist, E., et al. Allergy. 2013; 68: 285– 296

The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414

A compendium answering 150 questions on COVID-19 and SARS-CoV-2

Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541

Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19

Bousquet, J., Anto, J.M., Czarlewski, W., Haahtela, T. Fonseca, S.,C., Iaccarino, G. et al. Allergy. 2021; 76: 735– 750

Eleven faces of coronavirus disease 2019

Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709

Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course

Larenas-Linnemann, D.,E. and Rodríguez-Monroy, F. Allergy. 2021; 76: 910-914

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160

Asthma and COVID-19: Is asthma a risk factor for severe outcomes?

Johnston, S.,L. Allergy. 2020; 75: 1543-1545

Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection

Maurer, D.J., Barletta, E., Heider, A., et al. Allergy. First published: 12 June 2022

T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19

Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022

Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses

Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 14 May 2022

COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab

Francis, C.H.R., Hearn, A.P., Ratnakumar, S., et al. Allergy. First published: 01 May 2022

Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern

Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022

Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures

Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022

Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants

Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022

Are health care policies for COVID-19 evidence-based?

Bonini, S. and Fiorito, S. Allergy. First published: 30 March 2022

Virus-related stimuli modulate SARS-CoV-2 entry factor expression in pediatric tonsillar epithelial cells in vitro

Hara, M., Morimoto, N., Watabe, T., et al. Allergy. First published: 29 March 2022

Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?

Eberlein, B., Sonja, M., Fischer, J., Darsow, U., Biedermann, T. and Brockow, K. Allergy. First published: 10 March 2022

Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization

Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022

Has the Spring 2020 lockdown modified the relationship between air pollution and COVID-19 mortality in Europe?

Annesi-Maesano, I., Maesano, C.N., Dessimond, B., et al. Allergy. First published: 25 February 2022

Omicron: A SARS-CoV-2 variant of real concern

Gattinger, P., Tulaeva, I., Borochova, K., et al. Allergy. First published: 21 February 2022

Comparative assessment of allergic reactions to COVID-19 vaccines in Europe and the United States

Hatziantoniou, S., Anastassopoulou, C., Lampropoulou, V., et al. Allergy. First published: 16 February 2022

Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19

Sadlier, C., Albrich, W.C., Neogi, et al. Allergy. First published: 12 February 2022

COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendations

Jutel, M., Torres, M.J., Palomares, O., et al. Allergy. First published: 11 February 2022

Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination

Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 06 February 2022

Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study

Horn, MP, Jonsdottir, HR, Brigger, D, et al. Allergy. First published: 05 January 2022

Management of anaphylaxis due to COVID-19 vaccines in the elderly

Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964

Predictors of treatment response in chronic spontaneous urticaria

Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981

Interleukin-31: The “itchy” cytokine in inflammation and therapy

Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997

Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review

Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016

Eczema herpeticum in atopic dermatitis

Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027

Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study

Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052

Direct assessment of individual skin barrier components by electrical impedance spectroscopy

Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106

Prenatal paraben exposure and atopic dermatitis-related outcomes among children

Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132

Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis

Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154

Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy

Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193

Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine

Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196

Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma

Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202

Identification of Ulocladium chartarum as an important indoor allergen source

Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206

Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis

Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214

Legends of allergy and immunology: Sergio Bonini

Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229

Medical algorithm: Peri-operative management of mastocytosis patients

Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235

Junior Members Corner


Dear Junior Members,


Do not miss the Master Class on Adolescents and Young Adults!



It will take place in person on 20-21 May 2022, in Geneva (Switzerland). The main goal of the Master Class is to understand the challenges faced by adolescents and young adults with allergies and asthma, why adolescents and young adults are at risk patients, and to learn how help adolescents and young adults better self-manage their allergies and asthma. The Master Class will be held by a panel of experts and the organising chairs are Dr G. Roberts, Dr M. Vazquez-Ortiz and Dr P. Eigenmann (also editor-in-chief of the EAACI Paediatric Allergy and Immunology Journal).

If you are interested in participating, you can find more information through the link.

Look forward to seeing you there!

Best regards,
The Junior Member Assembly

See more in the JM archive